Latest News

Yale Cancer Center (YCC) scientists have identified mutations in metabolite-producing genes as a disruption of DNA repair.

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) scientists and clinicians are presenting research studies at the 2020 Annual Virtual Meeting of the American Society of Clinical Oncology (ASCO) May 29 – 31.

Sanjay Aneja, MD, of Yale School of Medicine, recently spoke with ASCO Daily News as part of a special series on treating patients with cancer in the wake of the severe acute respiratory syndrome coronavirus-2 (SARSCoV-2 [COVID-19]) within the United States.

Peschel was recognized as a leader in the field of radiation oncology, a dedicated and compassionate clinician, and an outstanding mentor with a remarkable attention to detail.

Who among us hasn't had a sore throat, a hoarse voice or a lump in the neck? Usually these are minor problems that go away on their own or after a course of antibiotics—but if they don't, check in with your doctor.

These cancers are on the rise among men, and HPV is causing the uptick. The Centers for Disease Control and Prevention (CDC) estimates that 79 million Americans are infected with HPV and that 90% of men and 80% of women will be infected with the virus at some point in their lives.

Humanized mice created at Yale are opening new avenues of research into cancers caused by disorders in the production of blood, such as acute myelogenous leukemia (AML) and myelodysplastic syndromes (MDS). Until recently, such research was hindered because human blood stem cells are difficult to grow in cell cultures or to engraft in mice.

To Parker Sulkowski, the next step was obvious, but he also knew that others would be racing to get there first. A PhD student in the lab of Peter Glazer, MD, PhD, Dr. Sulkowski was about to take what he learned from their groundbreaking study of glioma and look for other targets.

When the pros get sick, here’s how they find a physician.